Market Overview:
The global psychotherapeutic drugs market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of mental disorders, rising geriatric population, and growing demand for combination therapies. The hospital pharmacies segment is expected to account for the largest share of the global psychotherapeutic drugs market in 2018, followed by retail pharmacies and online pharmacies segments. North America is expected to dominate the global psychotherapeutic drugs market in 2018, followed by Europe and Asia Pacific.
Product Definition:
A psychotherapeutic drug is a psychiatric medication used to treat mental or emotional disorders. These drugs include antidepressants, antipsychotics, and anxiolytics. Psychotherapeutic drugs are important because they can help people with mental illness lead healthier, more productive lives.
Antipsychotic Drugs:
Antipsychotic drugs are used to treat psychotic disorders, which include symptoms such as hallucinations, paranoia, and thinking abnormalities. These symptoms indicate a problem with the chemical composition of the brain.
Antidepressants:
Antidepressants are used in the treatment of Major Depressive Disorder (MDD) and other psychiatric disorders. They work by increasing the amount of serotonin, a chemical in the brain, which helps to improve mood and reduce depression.
The global antidepressants market is expected to grow at a CAGR of XX% over the forecast period owing to an increase in awareness about mental health coupled with growing acceptance for prescribed medication for depression especially by young people.
Application Insights:
Based on application, the global market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. The hospital pharmacy segment dominated the market in 2017 owing to factors such as an increase in patients with mental disorders requiring drug treatment and a growing number of hospitals across the globe. Furthermore, an increasing number of pharmaceutical companies developing drugs specifically for treating mental disorders is also expected to drive demand over the forecast period.
The online pharmacy segment is anticipated to witness significant growth during the forecast period due to various benefits offered by these e-pharmacies such as convenience and accessibility along with low prices compared to traditional brick-and-mortar stores. Moreover, regulatory authorities have issued licenses allowing pharmacists who are registered practitioners at least one working day for providing medication via email or internet without visiting patient¢â‚¬â„¢s residence or place of work which will further boost industry growth during next few years (2017 - 2030 ).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing cases of mental disorders, rising awareness about available treatment methods, and availability of a large number of pharmaceutical products. Moreover, high healthcare expenditure and presence of major players are also contributing towards growth in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to improving economic conditions and growing disposable income levels in emerging countries such as China & India. Furthermore, government initiatives for improving public health system are likely to contribute toward increased demand for psychotherapeutic drugs over the coming years.
Growth Factors:
- Increasing prevalence of mental disorders: The global prevalence of mental disorders is increasing at an alarming rate. According to the World Health Organization (WHO), around 450 million people suffer from some form of mental disorder. This number is expected to increase to more than 600 million by 2020. This growing population of patients with mental disorders is expected to drive the demand for psychotherapeutic drugs in the coming years.
- Rising awareness about mental health: There is a growing awareness about the importance of good mental health and its impact on overall well-being among people across all age groups, genders, and geographies. This increased awareness is likely to lead to an increase in demand for psychotherapeutic drugs in the coming years.
- Growing use of antidepressants: Antidepressants are one of the most commonly prescribed types of psychotherapeutic drugs and their use is increasing rapidly worldwide due to their efficacy in treating various forms of depression and anxiety disorders. The rising use of antidepressants is likely to drive growth in the global market for psychotherapeutic drugs in the coming years..
Scope Of The Report
Report Attributes
Report Details
Report Title
Psychotherapeutic Drugs Market Research Report
By Type
Antipsychotic Drugs, Antidepressants, Psychotherapeutic Combinations
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Eli Lilly, Johnson&Johnson, Pfizer, Bristol-Myers Squibb, Allergan, GlaxoSmithKline, AstraZeneca, Astellas Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
128
Number of Tables & Figures
90
Customization Available
Yes, the report can be customized as per your need.
Global Psychotherapeutic Drugs Market Report Segments:
The global Psychotherapeutic Drugs market is segmented on the basis of:
Types
Antipsychotic Drugs, Antidepressants, Psychotherapeutic Combinations
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Eli Lilly
- Johnson&Johnson
- Pfizer
- Bristol-Myers Squibb
- Allergan
- GlaxoSmithKline
- AstraZeneca
- Astellas Pharma
Highlights of The Psychotherapeutic Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antipsychotic Drugs
- Antidepressants
- Psychotherapeutic Combinations
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Psychotherapeutic Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Psychotherapeutic drugs are medications used to treat mental disorders. They can be prescribed by a doctor, and they may be in the form of pills, injections, or creams.
Some of the key players operating in the psychotherapeutic drugs market are Eli Lilly, Johnson&Johnson, Pfizer, Bristol-Myers Squibb, Allergan, GlaxoSmithKline, AstraZeneca, Astellas Pharma.
The psychotherapeutic drugs market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Psychotherapeutic Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Psychotherapeutic Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Psychotherapeutic Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Psychotherapeutic Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Psychotherapeutic Drugs Market Size & Forecast, 2018-2028
4.5.1 Psychotherapeutic Drugs Market Size and Y-o-Y Growth
4.5.2 Psychotherapeutic Drugs Market Absolute $ Opportunity
Chapter 5 Global Psychotherapeutic Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Psychotherapeutic Drugs Market Size Forecast by Type
5.2.1 Antipsychotic Drugs
5.2.2 Antidepressants
5.2.3 Psychotherapeutic Combinations
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Psychotherapeutic Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Psychotherapeutic Drugs Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Psychotherapeutic Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Psychotherapeutic Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Psychotherapeutic Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Psychotherapeutic Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Psychotherapeutic Drugs Market Size Forecast by Type
9.6.1 Antipsychotic Drugs
9.6.2 Antidepressants
9.6.3 Psychotherapeutic Combinations
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Psychotherapeutic Drugs Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Psychotherapeutic Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Psychotherapeutic Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Psychotherapeutic Drugs Market Size Forecast by Type
10.6.1 Antipsychotic Drugs
10.6.2 Antidepressants
10.6.3 Psychotherapeutic Combinations
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Psychotherapeutic Drugs Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Psychotherapeutic Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Psychotherapeutic Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Psychotherapeutic Drugs Market Size Forecast by Type
11.6.1 Antipsychotic Drugs
11.6.2 Antidepressants
11.6.3 Psychotherapeutic Combinations
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Psychotherapeutic Drugs Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Psychotherapeutic Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Psychotherapeutic Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Psychotherapeutic Drugs Market Size Forecast by Type
12.6.1 Antipsychotic Drugs
12.6.2 Antidepressants
12.6.3 Psychotherapeutic Combinations
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Psychotherapeutic Drugs Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Psychotherapeutic Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Psychotherapeutic Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Psychotherapeutic Drugs Market Size Forecast by Type
13.6.1 Antipsychotic Drugs
13.6.2 Antidepressants
13.6.3 Psychotherapeutic Combinations
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Psychotherapeutic Drugs Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Psychotherapeutic Drugs Market: Competitive Dashboard
14.2 Global Psychotherapeutic Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Eli Lilly
14.3.2 Johnson&Johnson
14.3.3 Pfizer
14.3.4 Bristol-Myers Squibb
14.3.5 Allergan
14.3.6 GlaxoSmithKline
14.3.7 AstraZeneca
14.3.8 Astellas Pharma
